Ali Al-Khafaji, MD, MPH, FCCM
Education & Training
MD, Al-Mustansiriya University, 1993
MPH, Health Services Research, London School of Hygiene and Tropical Medicine, 2004
Residency, Internal Medicine, UPMC Mercy, 1999
Fellowship, Critical Care Medicine, Dartmouth Medical School, 2001
Fellowship, Anesthesia and Critical Care, University College London, 2005
Research, Clinical & Academic Interests
- Critical care hepatology
- Post-operative care in liver transplantation
- Acute kidney injury in patients with liver disease
DellaVolpe J, Al-Khafaji A. Acute Kidney Injury Before and After Liver Transplant. J Intensive Care Med. 2018 Jul 30:885066618790558. doi: 10.1177/0885066618790558. [Epub ahead of print]
Thompson J, Jones N, Al-Khafaji A, et al for the VTI-208 Study Group. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018 Mar;24(3):380-393.
Amathieu R, Al-Khafaji A, Sileanu FE, Foldes E, DeSensi R, Hilmi I, Kellum JA. Significance of oliguria in critically ill patients with chronic liver disease. Hepatology. 2017 Nov;66(5):1592-1600.
Al-Khafaji A, Elder M, Lebovitz DJ, Murugan R, Souter M, Stuart S, Wahed AS, Keebler B, Dils D, Mitchell S, Shutterly K, Wilkerson D, Pearse R, Kellum JA. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015 Mar;41(3):418-26.
Medical Director, Transplant Intensive Care Unit, UPMC Presbyterian-Montefiore
Director of ICU Telemedicine, Department of Critical Care Medicine
Fellow, American College of Critical Care Medicine, 2016
Pittsburgh Magazine’s list of the “Best Doctors in Pittsburgh” for 2016-2018